Cargando…
MEK inhibition leads to BRCA2 downregulation and sensitization to DNA damaging agents in pancreas and ovarian cancer models
Targeting the DNA damage response (DDR) in tumors with defective DNA repair is a clinically successful strategy. The RAS/RAF/MEK/ERK signalling pathway is frequently deregulated in human cancers. In this study, we explored the effects of MEK inhibition on the homologous recombination pathway and exp...
Autores principales: | Vena, Francesca, Jia, Ruochen, Esfandiari, Arman, Garcia-Gomez, Juan J., Rodriguez-Justo, Manuel, Ma, Jianguo, Syed, Sakeena, Crowley, Lindsey, Elenbaas, Brian, Goodstal, Samantha, Hartley, John A., Hochhauser, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837749/ https://www.ncbi.nlm.nih.gov/pubmed/29545922 http://dx.doi.org/10.18632/oncotarget.24294 |
Ejemplares similares
-
Comprehensive Two- and Three-Dimensional RNAi Screening Identifies PI3K Inhibition as a Complement to MEK Inhibitor AS703026 for Combination Treatment of Triple-Negative Breast Cancer
por: Lee, Jangsoon, et al.
Publicado: (2015) -
Cryptococcemia in pancreas-kidney transplant patient
por: Qasem, Anass, et al.
Publicado: (2023) -
Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignancies
por: Goodstal, Samantha M., et al.
Publicado: (2023) -
A phase I study of the HDM2 antagonist SAR405838 combined with the MEK inhibitor pimasertib in patients with advanced solid tumours
por: de Weger, Vincent A., et al.
Publicado: (2018) -
TGFβ engages MEK/ERK to differentially regulate benign and malignant pancreas cell function
por: Principe, D R, et al.
Publicado: (2017)